Literature DB >> 19330909

Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.

Pilaiwanwadee Hutamekalin1, Takayuki Saito, Kouya Yamaki, Nobuaki Mizutani, David D Brand, Takaki Waritani, Kuniaki Terato, Shin Yoshino.   

Abstract

A cocktail of 4 monoclonal anti-type II collagen antibodies recognizing conserved epitopes located within the CB11 fragment (CII 124-402) of type II collagen is currently used as an arthritogenic antibody preparation for inducing collagen antibody induced arthritis (CAIA). In order to increase the arthritogenicity of this cocktail, we have developed 7 new monoclonal antibodies to anti-type II collagen from spleen cells of DBA/1J mice immunized with bovine type II collagen, and tested for their additional effect on the arthritogenicity over that of the current 4-clone cocktail. Three of the clones (CII-3, -5 and -6) bind to the LyC1 (CII 124-290) peptide of CB11 and 1 (CII-7) of the clones binds to CB9.7 (CII 898-1020), and highly cross-reacted with other species of type II collagen. This indicates that these clones recognize conserved epitopes within type II collagen, including mouse type II collagen. On the other hand, 2 other clones (CII-1 and -4) directed against CB9.7 and 1 clone (CII-2) against CB8 (CII 403-551) were less reactive with other species of type II collagen. The arthritogenicity of the current 4-clone cocktail was significantly increased by addition of a fifth clone, CII-3. No effects were observed with other clones. The arthritogenicity of this new 5-clone cocktail was 2-fold greater than the current 4-clone cocktail in all strains of mice tested: the CIA-responder strain DBA/1J, the CIA-resistant BALB/c (H-2(d)), the T-cell deficient C.B-17/l scid/scid and the CAIA-low responder C57BL/6 (H-2(b)) strain. These results clearly indicated the importance of epitope specificity of arthritogenicity of autoantibodies to type II collagen. Due to its enhanced arthritogenicity, this 5-clone cocktail is capable of inducing a more consistent and severe arthritis with lower doses compared to the current 4-clone cocktail, and will provide an effective new reagent for inducing arthritis in various strains of CAIA low responder mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330909     DOI: 10.1016/j.jim.2009.01.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  31 in total

1.  Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis.

Authors:  Bonnie Williams; Eleni Tsangari; Romany Stansborough; Victor Marino; Melissa Cantley; Anak Dharmapatni; Rachel Gibson; Egon Perilli; Tania Crotti
Journal:  Inflammopharmacology       Date:  2017-01-03       Impact factor: 4.473

Review 2.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

3.  Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis.

Authors:  Yanpeng Li; Dongmei Tong; Peibin Liang; Erik Lönnblom; Johan Viljanen; Bingze Xu; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2020-05-24       Impact factor: 5.156

4.  Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies.

Authors:  Laren A Lofchy; Vivian P Vu; Nirmal K Banda; Joseline Ramos Ramirez; Weston J Smith; Geoffrey Gifford; Hanmant Gaikwad; Robert I Scheinman; Dmitri Simberg
Journal:  Mol Pharm       Date:  2019-05-15       Impact factor: 4.939

5.  ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis.

Authors:  Hideshi Yamazaki; Michiko Takeoka; Masato Kitazawa; Takashi Ehara; Naoki Itano; Hiroyuki Kato; Shun'ichiro Taniguchi
Journal:  Rheumatol Int       Date:  2011-02-18       Impact factor: 2.631

6.  CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice.

Authors:  Minami Matsuhashi; Keiichiro Nishida; Misa Sakamoto; Yuka Gion; Aki Yoshida; Takayuki Katsuyama; Ryuichi Nakahara; Yoshihisa Nasu; Yoshinori Matsumoto; Yasuharu Sato; Toshifumi Ozaki
Journal:  Inflamm Res       Date:  2022-01-22       Impact factor: 4.575

7.  Suppression of ongoing experimental arthritis by a chinese herbal formula (huo-luo-xiao-ling dan) involves changes in antigen-induced immunological and biochemical mediators of inflammation.

Authors:  Ying-Hua Yang; Rajesh Rajaiah; David Y-W Lee; Zhongze Ma; Hua Yu; Harry H S Fong; Lixing Lao; Brian M Berman; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

Review 8.  Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.

Authors:  Brad Bolon; Marina Stolina; Caroline King; Scot Middleton; Jill Gasser; Debra Zack; Ulrich Feige
Journal:  J Biomed Biotechnol       Date:  2010-12-28

9.  Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1.

Authors:  Tetsuo Hasegawa; Junichi Kikuta; Takao Sudo; Yoshinobu Matsuura; Takahiro Matsui; Szandor Simmons; Kosuke Ebina; Makoto Hirao; Daisuke Okuzaki; Yuichi Yoshida; Atsushi Hirao; Vladimir V Kalinichenko; Kunihiro Yamaoka; Tsutomu Takeuchi; Masaru Ishii
Journal:  Nat Immunol       Date:  2019-11-18       Impact factor: 25.606

10.  Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis.

Authors:  Petya Dimitrova; Nina Ivanovska; Lyudmila Belenska; Viktoriya Milanova; Wilhelm Schwaeble; Cordula Stover
Journal:  Arthritis Res Ther       Date:  2012-07-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.